The DOI matches its Crossref record; 29 of the 31 references it cites were found in a registry or an index.
Eliminating Racial Disparities in Colorectal Cancer in the Real World: It Took a Village
Open accessAbstract
Colorectal cancer (CRC) is the third most common cancer in the United States, with more than 102,000 new patients diagnosed per year. 1 It is, however, one of the few cancers that is highly preventable through the use of routine screening, 2 which can also prevent death resulting from CRC. 3,4 CRC is also one cancer that continues to demonstrate widening incidence and survival disparities between whites and African Americans.1,5 Although the reasons for these disparities are multifactorial, advanced stage at diagnosis may explain up to 50% of the survival disparity.6 This reality is not unique to CRC.Those who are poor, underserved, or minorities are more likely to get cancer and die as a result of it than those who are rich or white.This is a fact, and it is the current reality of cancer care in the United States, as documented in thousands of peer-reviewed articles, including the focus of an Institute of Medicine report.6a The shame for CRC is that the higher incidence rates and advanced stage of diagnosis are likely affected by differences in screening rates between whites and racial and ethnic minority populations.Multiple studies have documented lower rates of up-to-date screening among minority patients as well as lower rates of screening with colonoscopy.[7][8][9][10][11] Other studies have also found lower rates of follow-up for abnormalities detected on screening among minorities.12 Lack of insurance and usual sources of care certainly contribute to these disparities, but even when screening is universally provided, such as in the Medicare program, screening rates and follow-up after abnormal findings are still lower among African Americans compared with whites.7,13,14 Several randomized trials have demonstrated that provision of CRC screening combined with outreach efforts can significantly increase CRC screening rates among minority populations.[15][16][17][18][19] Moreover, patient navigation can increase the proportion of patients who receive appropriate and timely follow-up for abnormalities and facilitate the timely start of treatment.[20][21][22] In Journal of Clinical Oncology, Robbins et al 23 reported on a study that identified disparities in CRC mortality rates among African American patients with late-stage disease.In an editorial, Paskett 24 suggested three steps to reduce CRC disparities: one, increase CRC
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The annual bill for the screening and treatment program was $7 million but the annual savings from reduced incidence of CRC was $8.5 million.”
From Reducing Racial Inequities in Health: Using What We Already Know to Take Action (2019) · cites this paper as [59]
In the citing paper
“The mortality gap was almost eliminated by 2009 with a mortality decline of 42% for blacks and 13% for whites.”
From Reducing Racial Inequities in Health: Using What We Already Know to Take Action (2019) · cites this paper as [59]
In the citing paper
“A statewide colorectal cancer (CRC) initiative in the state of Delaware illustrates that a concerted effort can produce striking changes in a relatively short time [59].”
From Reducing Racial Inequities in Health: Using What We Already Know to Take Action (2019) · cites this paper as [59]
In the citing paper
“By 2009, colonoscopy screening rates had increased by 54% for blacks and 29% for whites and the racial gap in screening was eliminated.”
From Reducing Racial Inequities in Health: Using What We Already Know to Take Action (2019) · cites this paper as [59]
In the citing paper
“Similarly, a 34% decline in CRC incidence for African Americans and a 26% decline for whites led to the equalization of the incidence rates.”
From Reducing Racial Inequities in Health: Using What We Already Know to Take Action (2019) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unequal treatment: confronting racial and ethnic disparities in health care
(2003) · Choice Reviews Online · doi:10.5860/choice.40-5843 · Cited by 7,043
Capps, L. (2003) · JAMA · doi:10.1001/jama.290.18.2487-b · Cited by 4,558
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, G. M., Schuman, L. M., & Ederer, F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281901 · Cited by 3,220
Projections of the cost of cancer care in the United States: 2010–2020
Mariotto, A. B., Robin Yabroff, K., Shao, Y., Feuer, E. J., & Brown, M. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq495 · Cited by 2,657
Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00243 · Cited by 1,957
Atkin, W. S., Edwards, R., Kralj‐Hans, I., Wooldrage, K., Hart, A. R., Northover, J. M. A., Parkin, D. M., Wardle, J., Duffy, S. W., & Cuzick, J. M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60551-x · Cited by 1,618
Patterns of Colorectal Cancer Screening Uptake among Men and Women in the United States
Meissner, H. I., Breen, N., Klabunde, C. N., & Vernon, S. W. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0678 · Cited by 571
Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer
Tammemägi, M. C. (2005) · JAMA · doi:10.1001/jama.294.14.1765 · Cited by 428
Percac‐Lima, S., Grant, R. W., Green, A. R., Ashburner, J. M., Gamba, G. B., Oo, S. A., Richter, J. M., & Atlas, S. J. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0864-x · Cited by 344
Jandorf, L. H. (2005) · Journal of Urban Health · doi:10.1093/jurban/jti046 · Cited by 229
Research works printed but not linked: 4
- Howlader N, 2012, SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations)
- American Cancer Society, 2008, Colorectal Cancer Facts and Figures for African Americans 2008-2010
- James TM, 2006, Ethn Dis, 16, 228
- Hu CY, 2011, Am J Manag Care, 17, 329
Cited by
Sorted by citations
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21820 · Cited by 9,533
Colorectal cancer statistics, 2014
Siegel, R. L., Desantis, C. E., & Jemal, A. (2014) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21220 · Cited by 2,598
Breast cancer statistics, 2017, racial disparity in mortality by state
Desantis, C. E., Ma, J., Sauer, A. G., Newman, L. A., & Jemal, A. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21412 · Cited by 1,879
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Lheureux, S., Braunstein, M., & Oza, A. M. (2019) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21559 · Cited by 1,468
Metadata
- Authors
- Grubbs, S. S., Polite, B. N., Carney, J., Bowser, W., Rogers, J., Katurakes, N., Hess, P., & Paskett, E. D.
- Affiliations
- Delaware Cancer Consortium, Dover; and Helen F. Graham Cancer Center, Newark, DE
- The University of Chicago, Chicago, IL
- United States House of Representatives (US)
- Delaware Cancer Consortium, Dover, DE
- Delaware Division of Public Health (US)
- The Ohio State University (US)
- Venue
- Journal of Clinical Oncology
- Published
- 2013-06-01
- Volume
- 31
- Issue
- 16
- Pages
- 1928-1930
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- PMC
- PMC3661932
- OpenAlex
- W2131142429
- Cited by
- 201
- References
- 31
- Citations by year
- 2026: 5 · 2025: 22 · 2024: 28 · 2023: 18 · 2022: 18 · 2021: 12 · 2020: 11 · 2019: 17 · 2018: 7 · 2017: 8 · 2016: 15 · 2015: 19 · 2014: 18 · 2013: 3
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Oncology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P30CA016058)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Social Sciences › Health › Health disparities and outcomes
- Keywords
- colorectal cancer, racial disparities, African Americans, colorectal cancer screening, patient navigation, screening outreach, colonoscopy, delayed diagnosis, health disparities, underserved populations
- MeSH terms
- Black or African American, Female, Humans, Male, Colorectal Neoplasms, White People, Healthcare Disparities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
